Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
12.46
-0.16 (-1.27%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Orthofix Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 82.03 | 83.24 | 33.11 | 50.7 | 87.85 | Upgrade
|
| Cash & Short-Term Investments | 82.03 | 83.24 | 33.11 | 50.7 | 87.85 | Upgrade
|
| Cash Growth | -1.46% | 151.42% | -34.70% | -42.29% | -8.77% | Upgrade
|
| Receivables | 135.75 | 134.71 | 128.1 | 82.86 | 78.56 | Upgrade
|
| Inventory | 172.32 | 189.45 | 222.17 | 100.15 | 82.97 | Upgrade
|
| Prepaid Expenses | 23.67 | 23.38 | 32.42 | 22.28 | 20.14 | Upgrade
|
| Restricted Cash | 3.09 | 2.5 | 4.65 | - | - | Upgrade
|
| Total Current Assets | 416.85 | 433.29 | 420.44 | 255.99 | 269.52 | Upgrade
|
| Property, Plant & Equipment | 151.68 | 157.04 | 178.93 | 65.02 | 62.41 | Upgrade
|
| Long-Term Investments | - | - | 6.26 | 6.08 | 5.41 | Upgrade
|
| Goodwill | 194.93 | 194.93 | 194.93 | 71.32 | 71.32 | Upgrade
|
| Other Intangible Assets | 72.77 | 98.8 | 117.49 | 47.39 | 52.67 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | 1.1 | 1.4 | Upgrade
|
| Long-Term Deferred Tax Assets | 1.88 | 1.54 | 2.08 | 1.47 | - | Upgrade
|
| Long-Term Deferred Charges | 1.3 | 1.1 | 1.9 | 0.7 | 1 | Upgrade
|
| Other Long-Term Assets | 11.25 | 6.59 | 3.28 | 2.42 | 5.75 | Upgrade
|
| Total Assets | 850.65 | 893.29 | 925.32 | 458.63 | 476.62 | Upgrade
|
| Accounts Payable | 58.39 | 48.8 | 58.36 | 27.6 | 26.46 | Upgrade
|
| Accrued Expenses | 94.6 | 98.66 | 93.28 | 49.1 | 49.94 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 1.25 | - | - | Upgrade
|
| Current Portion of Leases | 3.98 | 4.78 | 4.18 | 2.29 | 4.42 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 4.79 | Upgrade
|
| Other Current Liabilities | 13.51 | 16.39 | 8.15 | 4.63 | 20.22 | Upgrade
|
| Total Current Liabilities | 170.48 | 168.63 | 165.22 | 83.62 | 105.83 | Upgrade
|
| Long-Term Debt | 157.39 | 157.02 | 93.11 | - | - | Upgrade
|
| Long-Term Leases | 42.47 | 31.92 | 35.66 | 24.62 | 21.33 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 6.08 | 5.64 | 4.17 | 1.26 | 1.08 | Upgrade
|
| Other Long-Term Liabilities | 24.18 | 26.97 | 28.43 | 12.27 | 11.45 | Upgrade
|
| Total Liabilities | 400.61 | 390.17 | 326.59 | 121.77 | 139.69 | Upgrade
|
| Common Stock | 3.98 | 3.85 | 3.72 | 2.02 | 1.98 | Upgrade
|
| Additional Paid-In Capital | 813.77 | 779.72 | 746.45 | 334.97 | 313.95 | Upgrade
|
| Retained Earnings | -368.33 | -276.14 | -150.14 | 1.25 | 21 | Upgrade
|
| Comprehensive Income & Other | 0.62 | -4.3 | -1.29 | -1.38 | - | Upgrade
|
| Shareholders' Equity | 450.04 | 503.12 | 598.73 | 336.86 | 336.93 | Upgrade
|
| Total Liabilities & Equity | 850.65 | 893.29 | 925.32 | 458.63 | 476.62 | Upgrade
|
| Total Debt | 203.85 | 193.71 | 134.2 | 26.91 | 25.76 | Upgrade
|
| Net Cash (Debt) | -121.82 | -110.47 | -101.09 | 23.8 | 62.09 | Upgrade
|
| Net Cash Growth | - | - | - | -61.68% | -9.23% | Upgrade
|
| Net Cash Per Share | -3.08 | -2.90 | -2.75 | 1.19 | 3.15 | Upgrade
|
| Filing Date Shares Outstanding | 40.14 | 39.02 | 37.41 | 36.46 | 19.85 | Upgrade
|
| Total Common Shares Outstanding | 39.83 | 38.49 | 37.17 | 20.16 | 19.84 | Upgrade
|
| Working Capital | 246.37 | 264.66 | 255.22 | 172.37 | 163.69 | Upgrade
|
| Book Value Per Share | 11.30 | 13.07 | 16.11 | 16.71 | 16.99 | Upgrade
|
| Tangible Book Value | 182.34 | 209.39 | 286.31 | 218.16 | 212.95 | Upgrade
|
| Tangible Book Value Per Share | 4.58 | 5.44 | 7.70 | 10.82 | 10.74 | Upgrade
|
| Buildings | 4.4 | 3.87 | 4.1 | 3.87 | 3.93 | Upgrade
|
| Machinery | 286.21 | 262.7 | 235.45 | 148.88 | 159.1 | Upgrade
|
| Construction In Progress | 23.24 | 22.69 | 41.75 | 4.52 | 2.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.